Detailed answers about RESTART MEDICAL & AESTHETICS CLINIC LIMITED, including incorporation, status, business activity, and accounts information.
When was RESTART MEDICAL & AESTHETICS CLINIC LIMITED founded?
RESTART MEDICAL & AESTHETICS CLINIC LIMITED was officially incorporated on 25 January 2024 and is registered under company number 15442614. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is RESTART MEDICAL & AESTHETICS CLINIC LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of RESTART MEDICAL & AESTHETICS CLINIC LIMITED?
RESTART MEDICAL & AESTHETICS CLINIC LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does RESTART MEDICAL & AESTHETICS CLINIC LIMITED do?
RESTART MEDICAL & AESTHETICS CLINIC LIMITED operates in the following sector: 86220 - Specialists medical practice activities. This provides insight into the company's primary business activity and industry focus.
What is RESTART MEDICAL & AESTHETICS CLINIC LIMITED's registered address?
The registered office address of RESTART MEDICAL & AESTHETICS CLINIC LIMITED is 45 MAIN STREET, WILLOUGHBY ON THE WOLDS, LOUGHBOROUGH, ENGLAND, LE12 6SY. This is the official address filed with Companies House for legal and statutory correspondence.
Is RESTART MEDICAL & AESTHETICS CLINIC LIMITED financially stable?
The most recent accounts for RESTART MEDICAL & AESTHETICS CLINIC LIMITED were made up to 31 January 2025, filed as MICRO ENTITY. Next accounts are due by 31 October 2026.